John Overdeck’s Edesa Biotech EDSA Stock Holding History

John Overdeck’s Portfolio EDSA Stock Details EDSA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$114K	Buy	+14,032	New	+$127K	﹤0.01%	4873
2023 Q3	–	Sell	-1,653	Closed	-$9.38K	–	3013
2023 Q2	$9.38K	Sell	1,653 -2,162	-57%	-$14.4K	﹤0.01%	2946
2023 Q1	$24.4K	Buy	+3,815	New	+$39.8K	﹤0.01%	2833
2022 Q2	–	Sell	-1,587	Closed	-$33K	–	2621
2022 Q1	$33K	Sell	1,587 -215	-12%	-$5.96K	﹤0.01%	2511
2021 Q4	$71K	Buy	+1,802	New	+$86.2K	﹤0.01%	4110
2021 Q1	–	Sell	-3,213	Closed	-$96K	–	3915
2020 Q4	$96K	Buy	+3,213	New	+$131K	﹤0.01%	3215

Other funds holding EDSA

VCIM

Velan Capital Investment Management Alpharetta, Georgia $164M AUM 542.31% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

SCM

Stonepine Capital Management Bend, Oregon $177M AUM 91.13% 1-Year Est. Return

BCM

Boxer Capital Management San Diego, California $1.33B AUM 864.5% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

John Overdeck's EDSA Position: Q2 2026 in Review

John Overdeck opened a new position in Edesa Biotech (EDSA) in Q2 2026: 14,032 shares worth $114K. The stake represents ﹤0.01% of the portfolio and ranks #4873 among its holdings. This is a return to the name: John Overdeck previously reported a position in EDSA as recently as Q2 2023.

John Overdeck first reported a position in EDSA in Q4 2020 and has held it in 6 quarters since. 33 funds tracked by Wall St. Rank hold EDSA as of Q2 2026.

John Overdeck held 14,032 shares of Edesa Biotech worth $114K as of Q2 2026.
Edesa Biotech was a new John Overdeck position in Q2 2026.
Edesa Biotech made up ﹤0.01% of John Overdeck's portfolio in Q2 2026, its #4873 holding.
John Overdeck first reported a position in Edesa Biotech in Q4 2020 and has held it in 6 quarters since.
33 funds tracked by Wall St. Rank held Edesa Biotech as of Q2 2026.

Based on Two Sigma Investments's 13F filing for Q2 2026, filed 14 Aug 2026.